DCF — LAFAYETTE SURGICAL SPECIALTY HOSPITA
Enterprise Value: $36.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$36.7M
Enterprise Value
$9.6M
PV of Cash Flows
$27.1M
PV of Terminal Value
$43.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $50.3M | $4.8M | 10.0% | $1.8M | $1.6M |
| Year 2 | $51.9M | $5.5M | 11.0% | $2.2M | $1.9M |
| Year 3 | $53.4M | $6.2M | 12.0% | $2.7M | $2.0M |
| Year 4 | $55.0M | $6.6M | 12.0% | $3.0M | $2.0M |
| Year 5 | $56.7M | $7.0M | 12.0% | $3.2M | $2.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $36.7M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$48.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09085159628754712
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5